| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |